Faktablad PDF

Marked: Copenhagen

Symbol: CHR

ISIN: DK0060227585

Chr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and HMOs for a variety of foods, beverages, dietary supplements, animal feed and crop protection.

Aktieoplysninger	28-06-2022
Valuta	DKK
Tidligere lukket	523,60
52 uger %	-7,50
Mængde	184.073
Antal aktier	131.852.496
Markedsværdi (mil.)	69,0

Sidste lukkekurs	Valuta	52 uger %	Volume	Antal aktier	Markedsværdi (mia.)
523,60	DKK	-7,50	184.073	131.852.496	69,0

Nøgletal, EUR mio


Resultatopgørelse (cont. operations)	2020/21	2019/20	2018/19	2017/18	2016/17
Omsætning	1.077,4	970,0	937,4	1.097,4	1.062,5
Bruttoresulta	613,4	584,0	576,9	600,6	578,1
EBITDA - før særlige poste	399,3	400,6	372,3	384,0	368,1
EBIT før særlige poster	298,1	326,9	314,7	320,2	307,1
EBIT	276,2	313,0	312,4	320,2	305,7
Finansielle poster, netto	(22,5)	(13,5)	(16,1)	(24,1)	(14,8)
Profit from continuing operations	198,7	231,6	229,2	228,2	224,0
Profit from discontinued operations	646,5	13,4	21,0	-	-
Årets resultat	845,2	245,0	250,2	228,2	224,0

Cash flow (Group)	2020/21	2019/20	2018/19	2017/18	2016/17
Pengestrøm fra driften	310,8	364,6	298,6	302,4	283,7
Cash flow from investing activities	284,5	(807,5)	(81,6)	(107,0)	(176,5)
Frie pengestrømme	595,3	(442,9)	217,0	195,4	107,2
Frie pengestrømme før opkøb og særlige poster	183,9	244,5	229,1	195,9	187,8
Free cash flow before acquisitions and special items, cont. operations	196,4	224,9	220,2	-	-

Balance (Group)	2020/21	2019/20	2018/19	2017/18	2016/17
Aktiver i alt ¹⁾	3.114,2	2.853,6	2.057,8	1.861,1	1.802,1
Investeret kapital ¹⁾	2.793,1	2.487,6	1.745,3	1.631,5	1.581,1
Nettodriftskapital ¹⁾	190,1	208,1	220,6	189,1	174,8
Egenkapital	1.626,1	893,0	797,2	771,6	768,5
Nettorentebærende gæld	898,2	1.345,0	734,4	658,7	628,4

Nøgletal	2020/21	2019/20	2018/19	2017/18	2016/17

Continuing operations
Organisk vækst, %	7	6	8	9	10
Bruttoavance, %	56,9	60,2	61,5	54,7	54,4
EBITDA margin før særlige poster, %	37,1	41,3	39,7	35,0	34,6
EBIT- før særlige poster, %	27,7	33,7	33,6	29,2	28,9
EBIT- margin, %	25,6	32,3	33,3	29,2	28,8
Afkast af gennemsnitlig investeret kapital ekskl. goodwill, %	24,8	33,6	39,2	38,0	40,1
Afkast af gennemsnitlig investeret kapital, %	11,6	16,8	20,3	19,9	20,3
Forskning og udvikling, %	8,5	8,0	8,1	7,3	7,0
Anlægsinvesteringer, %	14,5	12,2	12,6	9,8	10,0
EPS, fortsættende aktiviteter, udvandet	1,51	1,76	1,74	-	-
Gennemsnitligt antal ansatte	3.398	2.932	2.768	3.151	2.940

Group
EPS, fortsættende aktiviteter, udvandet	6,41	1,86	1,90	1,73	1,68
Nettorentebærende gæld/EBITDA	2,3x	3,1x	1,8x	1,7x	1,7x

Following the classification of the Natural Colors business as discontinued operations in 2019/20, the business is presented separately on an aggregated level in the income statement, balance sheet and cash flow statement. In accordance with IFRS, the income statement and the cash flow statement have both been restated in previous periods, while the balance sheet has not been restated in previous periods. The comparative figures for 2016/17 - 2017/18 have not been restated and are not directly comparable.

Numbers are not restated and therefore not directly comparable

¹⁾ The Natural Colors business was divested as of March 31, 2021. For the financial years 2016/17-2019/20, total assets, invested capital and net working capital include assets and liabilities related to the Natural Colors business.